D'Orazio & Associates’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $359K | Sell |
5,205
-731
| -12% | -$50.5K | 0.05% | 145 |
|
|
2025
Q1 | $412K | Sell |
5,936
-2,313
| -28% | -$161K | 0.06% | 116 |
|
|
2024
Q4 | $710K | Sell |
8,249
-401
| -5% | -$34.5K | 0.1% | 70 |
|
|
2024
Q3 | $1.03M | Sell |
8,650
-74
| -0.8% | -$8.81K | 0.15% | 55 |
|
|
2024
Q2 | $1.25M | Buy |
8,724
+69
| +0.8% | +$9.85K | 0.19% | 43 |
|
|
2024
Q1 | $1.11M | Buy |
8,655
+362
| +4% | +$46.5K | 0.18% | 46 |
|
|
2023
Q4 | $858K | Buy |
8,293
+1,159
| +16% | +$120K | 0.15% | 54 |
|
|
2023
Q3 | $649K | Buy |
7,134
+1,118
| +19% | +$102K | 0.15% | 60 |
|
|
2023
Q2 | $487K | Sell |
6,016
-786
| -12% | -$63.6K | 0.11% | 65 |
|
|
2023
Q1 | $541K | Sell |
6,802
-190
| -3% | -$15.1K | 0.14% | 57 |
|
|
2022
Q4 | $473K | Buy |
6,992
+956
| +16% | +$64.7K | 0.11% | 69 |
|
|
2022
Q3 | $301K | Sell |
6,036
-352
| -6% | -$17.6K | 0.09% | 90 |
|
|
2022
Q2 | $356K | Buy |
6,388
+2,020
| +46% | +$113K | 0.09% | 76 |
|
|
2022
Q1 | $243K | Buy |
+4,368
| New | +$243K | 0.06% | 88 |
|
|
2021
Q4 | – | Sell |
-1,326
| Closed | -$64K | – | 502 |
|
|
2021
Q3 | $64K | Buy |
+1,326
| New | +$64K | 0.02% | 173 |
|
|
2015
Q4 | – | Sell |
-560
| Closed | -$15K | – | 298 |
|
|
2015
Q3 | $15K | Buy |
+560
| New | +$15K | 0.01% | 167 |
|